COMMUNIQUÉS West-GlobeNewswire

Rhythm Pharmaceuticals to Report First Quarter 2026 Financial Results on Tuesday, May 5, 2026
09/04/2026
BOSTON, April 09, 2026 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global commercial-stage biopharmaceutical company focused on transforming the lives of patients living with rare neuroendocrine [...]
Cloudbreak Pharma Announces Launch of Cloudbreakpharma.com to Raise Awareness of its Pipeline of Novel First-in-Class Therapeutics to Treat Serious Underserved Ophthalmic Diseases
09/04/2026
Lead candidate, CBT-001 for the treatment of pterygium, a multi-billion-dollar addressable market, is in mid-Phase 3 with initial topline data anticipated in Q3 2026 Second asset, CBT-004 for the treatment of pinguecula [...]
Noom and b.well Partner to Launch Integrated Health Record Access for Medicare Members
09/04/2026
New integration delivers on Noom's pledge to the CMS Health Technology Ecosystem initiative to enable deeper personalization within Noom’s diabetes and obesity programs PRINCETON, N.J., April 09, 2026 (GLOBE NEWSWIRE [...]
Onconetix Highlights Realbotix's Launch of Vinci AI Vision System with Delivery of First Vinci-Equipped Humanoid Robot to Ericsson
09/04/2026
Vinci Enables Realbotix Robots to Recognize People, Recall Conversations, and Track Engagement; Onconetix Recently Entered into a Definitive Agreement to Acquire Realbotix LLC, a Subsidiary of Realbotix Corp. CINCINNATI [...]
Kestra Medical Technologies Named a 2026 USA TODAY Top Workplaces Award Winner
09/04/2026
KIRKLAND, Wash., April 09, 2026 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (Nasdaq: KMTS), a leading wearable medical device and digital healthcare company, today announced it has been named a 2026 USA TODAY [...]
Fedora Pharmaceuticals Showcasing Antibiotic Candidate at 2026 European Society of Clinical Microbiology and Infectious Diseases Congress
09/04/2026
EDMONTON, Alberta , April 09, 2026 (GLOBE NEWSWIRE) -- Fedora Pharmaceuticals, Inc., a leader in the development of drugs to treat antibiotic-resistant infections, intends to present a full suite of preclinical findings [...]
Zentalis Pharmaceuticals Announces 400mg QD 5:2 Azenosertib Monotherapy as the Pivotal Study Dose in Cyclin E1-Positive Platinum-Resistant Ovarian Cancer
09/04/2026
Planned interim analysis from DENALI Part 2a showed a clearly differentiated response rate at 400mg QD 5:2 over 300mg QD 5:2 and comparable safety profiles between the two dose groups Azenosertib therapeutic profile [...]
Sparian Biosciences Announces Initiation of Phase 1 Clinical Trial of SBS-147 Next Generation Arylepoxamide Agonist for the Treatment of Pain Funded by a $15M NIH Grant
09/04/2026
Phase 1 clinical trial will evaluate the safety, tolerability, and pharmacokinetics SBS-147 is a novel and potent oral analgesic with a differentiated safety profile being developed for acute and chronic pain The phase [...]
The Growing Connection Between Microplastics and the Human Heart
09/04/2026
Anathapindika Founder Speaks to Need for Detoxification in Supplementation: “Adding More Nutrients to Our Diets Is Not Enough for Healthy Living” Fort Lauderdale, FL, April 09, 2026 (GLOBE NEWSWIRE) -- The presence of [...]
Highridge Medical Enters Exclusive Distribution Agreement for the Waypoint GPS Enabling Technology Platform
09/04/2026
Highridge portfolio expands to include an innovative pedicle probe with real-time visual feedback. WESTMINSTER, Colo., April 09, 2026 (GLOBE NEWSWIRE) -- Highridge Medical, a leading privately held global spine company [...]
Over 60 Million Showed They Are #MoreThanMyeloma During 2026 Myeloma Action Month
09/04/2026
Myeloma Action Month Global Campaign Celebrated Resilience, Strengthened Connections, and Inspired Hope in 96 Countries STUDIO CITY, Calif., April 09, 2026 (GLOBE NEWSWIRE) -- As this year’s Myeloma Action Month came to [...]
Boehringer Ingelheim to evaluate innovative combination of DLL3‑targeting T‑cell engager plus PD‑L1/VEGF‑A bispecific antibody in small cell lung cancer
09/04/2026
Clinical trial collaboration and supply agreement between Boehringer and BioNTech to conduct a Phase Ib/II clinical trial to explore complementary immuno-oncology mechanisms in extensive‑stage small cell lung cancer. [...]
NKGen Biotech to Present Troculeucel Mechanism Data in Alzheimer’s and Frontotemporal Dementia at the Neuroimmunology Drug Development Summit
09/04/2026
SANTA ANA, Calif., April 09, 2026 (GLOBE NEWSWIRE) -- NKGen Biotech, Inc. (OTC: NKGN) (“NKGen” or the “Company”), a clinical-stage biotechnology company focused on the development and commercialization of innovative [...]
Cerevance to Present Positive Phase 2 Solengepras Data in Parkinson’s Disease at the American Academy of Neurology 2026 Annual Meeting
09/04/2026
Solengepras, a once-daily, oral, non-dopaminergic GPR6 inhibitor, demonstrated meaningful reductions in daily OFF time and improvements in sleep-related symptoms across two Phase 2 trials Meeting presentations highlight [...]
Akari Therapeutics Participates in Virtual Investor “What This Means” Interview Discussing Strategic Partnership with WuXi XDC
09/04/2026
CEO Abizer Gaslightwala discusses the Company’s strategic partnership with WuXi XDC and its implications for platform validation and development acceleration Company highlights accelerated IND timeline for AKTX-101 and [...]
Nautilus Biotechnology to Announce First Quarter 2026 Financial Results on April 28, 2026
09/04/2026
SEATTLE, April 09, 2026 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform, today announced it will report financial results [...]
Global Alzheimer’s Platform Foundation Announces Strategic Collaboration and Partnership with Siemens Healthineers for the Transformative Bio-Hermes-002 Study
09/04/2026
Siemens Healthineers joins collaborative study focused on new biomarkers designed to improve diagnosis of Alzheimer's disease and dementias WASHINGTON, April 09, 2026 (GLOBE NEWSWIRE) -- The Global Alzheimer’s Platform [...]
Myriad Genetics Underscores Commitment to Cancer Care Continuum with New Data Presentations at SGO Annual Meeting
09/04/2026
SALT LAKE CITY, April 09, 2026 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announces that it will share new data at the Society of [...]
Cardiology Consultants of Philadelphia Launches CCP Now, a Specialized Cardiac Walk-In Facility in Delaware County
09/04/2026
SPRINGFIELD, Pa., April 09, 2026 (GLOBE NEWSWIRE) -- Cardiology Consultants of Philadelphia (CCP), the region’s leading cardiology practice, today announced the grand opening of CCP Now, a cardiac walk-in facility [...]

Pages